LifeMD(LFMD) - 2023 Q3 - Earnings Call Presentation

Rapid growth in profitability after achieving adjusted EBITDA profit in Q4 '22 Annual consolidated adjusted EBITDA ($millions)$10-$11M 2022A$(15)M ($38)M 2023E 2021A Note: Consolidated adjusted EBITDA includes Telehealth and WorkSimpli results. 16 Rapidly expanding gross margins and increasing leverage on marketing spend driving continued growth in profitability 82$ Millions) 72% 55% 62% 50% 54% 51% 0% 25% 50% ...